Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015 (2015), Article ID 614845, 7 pages
http://dx.doi.org/10.1155/2015/614845
Research Article

Metastatic Salivary Gland Tumors: A Single-Center Study Demonstrating the Feasibility and Potential Clinical Benefit of Molecular-Profiling-Guided Therapy

1Institute of Oncology, Davidoff Center, Rabin Medical Center, 39 Jabotinsky Street, 49100 Petah Tikva, Israel
2Sackler Faculty of Medicine, Tel Aviv University, Ramat Aviv, 69978 Tel Aviv, Israel
3Radiology Department, Rabin Medical Center, 39 Jabotinsky Street, 49100 Petah Tikva, Israel
4Oncotest-Teva Pharmaceutical Industries, Ltd., Hatee’na 1, 60850 Shoham, Israel

Received 22 January 2015; Accepted 5 May 2015

Academic Editor: Murat Gokden

Copyright © 2015 Aron Popovtzer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Supplementary Material

The supplementary material provides details on the scoring system and cutoffs used for the immunohistochemistry analyses (Supplementary Table 1), as well as key molecular-profiling findings for each of the 14 patients in our study cohort (Supplementary Table 2).

  1. Supplementary Material